CLINICAL_TRIALS
trial_result
· 2019-01-31
Clinical Trial Update: A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neuralgia) [Phase 2]
Summary
Phase 2 trial evaluating brivaracetam for postherpetic neuralgia has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UCB Pharma | Conditions: Neuralgia, Postherpetic | Phase 2 | Status: COMPLETED | Results posted: 2019-01-31